Search results
Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
Digital Journal· 2 hours agoSecond study arm dosing is now complete. KELOWNA, BC / ACCESSWIRE / June 5, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug ...
Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns
Medical Xpress· 1 day ago"The current fervor for GLP-1RAs in the capital markets as well as in the general public, especially in terms of weight reduction, is probably going to result in overuse," said Chun-Su Yuan, ...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 22 hours agoGLP-1 medications function by addressing two critical pathways in glucose management: They enhance...
The Best Vitamin D Supplements
Eating Well via Yahoo News· 5 days agoWhile knowledge of vitamin D primarily centered around bone health in the past, research today shows that the hormone-like nutrient also regulates immune...
The heart health risks for midlife women – and how to beat them
The Telegraph via Yahoo News· 6 days agoWhen, in her late 40s, Rebecca Hutchinson started having hot flushes and dizzy spells, she thought...
Sucralose vs. Stevia: Which Sugar Substitute Is Right for You?
Verywell Fit via Yahoo News· 3 days agoSweet without the calories of table sugar? Sucralose and stevia are popular sugar substitutes, but...
The rise of self-diagnostics: 'The future of nutrition is hyper-personalized'
Nutraingredients.com· 6 hours agoMárcia Costa, research manager for healthcare at industry insight firm Deloitte Center for Health...
Mounjaro vs. Ozempic: Is One Better Than the Other For Weight Loss?
MediaFeed via AOL· 7 days agoIn one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...
Is coronary artery disease a genetic condition?
Medical News Today· 7 days agoWhat role does genetics play in the development of coronary artery disease? Read on to learn more, including other risk factors that may increase the...
Severe Hypoglycemia in Diabetes Drug Approved in Europe
Medscape· 5 days agoTreatment of insulin-induced hypoglycemia with Zegalogue reduced recovery time from severe...